Loading...
Please wait, while we are loading the content...
Similar Documents
Deregulation of Cdt1 induces chromosomal damage without rereplication and leads to chromosomal instability.
| Content Provider | Semantic Scholar |
|---|---|
| Author | Tatsumi, Yasutoshi Sugimoto, Nozomi Yugawa, Takashi Narisawa-Saito, Mako Kiyono, Tohru Fujita, Masatoshi |
| Copyright Year | 2006 |
| Abstract | The activity of human Cdt1 is negatively regulated by multiple mechanisms. This suggests that Cdt1 deregulation may have a deleterious effect. Indeed, it has been suggested that overexpression of Cdt1 can induce rereplication in cancer cells and that rereplication activates Ataxia-telangiectasia-mutated (ATM) kinase and/or ATM- and Rad3-related (ATR) kinase-dependent checkpoint pathways. In this report, we highlight a new and interesting aspect of Cdt1 deregulation: data from several different systems all strongly indicate that unregulated Cdt1 overexpression at pathophysiological levels can induce chromosomal damage other than rereplication in non-transformed cells. The most important finding in these studies is that deregulated Cdt1 induces chromosomal damage and activation of the ATM-Chk2 DNA damage checkpoint pathway even in quiescent cells. These Cdt1 activities are negatively regulated by cyclin A/Cdks, probably through modification by phosphorylation. Furthermore, we found that deregulated Cdt1 induces chromosomal instability in normal human cells. Since Cdt1 is overexpressed in cancer cells, this would be a new molecular mechanism leading to carcinogenesis. |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | http://jcs.biologists.org/content/joces/early/2006/07/11/jcs.03031.full.pdf |
| PubMed reference number | 16835273v1 |
| Volume Number | 119 |
| Part | 15 |
| Journal | Journal of cell science |
| Language | English |
| Access Restriction | Open |
| Subject Keyword | CDT1 Gene Carcinogenesis Cell Cycle Checkpoints Chromosomal Instability DNA Replication Factor DNA damage checkpoint Deregulation Episodic ataxia type 2 (disorder) Telangiectasis cancer cell |
| Content Type | Text |
| Resource Type | Article |